Cemented
cement
femur
megaproshesis
metastasis
Journal
Orthopedic reviews
ISSN: 2035-8237
Titre abrégé: Orthop Rev (Pavia)
Pays: United States
ID NLM: 101524779
Informations de publication
Date de publication:
29 Jun 2020
29 Jun 2020
Historique:
received:
16
06
2020
accepted:
17
06
2020
entrez:
11
9
2020
pubmed:
12
9
2020
medline:
12
9
2020
Statut:
epublish
Résumé
The proximal femur is the long bone most commonly affected by metastatic disease. There are many treatment options, such as hip megaprostheses. A topic still widely debated in literature is the use of cemented or uncemented megaprostheses in this kind of patients. The purpose of this review is to examine both these surgical options to understand which of them should be preferred in metastatic patients. Twelve articles were finally included in the review. Eight authors used cemented mega - prostheses, two cementless megaprostheses and two authors used both techniques. Better functional outcomes and lower infection rates were found in cementless mega - prostheses. More studies have to be performed to choose the better technique and improve patients' quality of life.
Identifiants
pubmed: 32913616
doi: 10.4081/or.2020.8689
pmc: PMC7459367
doi:
Types de publication
Journal Article
Langues
eng
Pagination
8689Informations de copyright
©Copyright: the Author(s).
Déclaration de conflit d'intérêts
Conflict of interest: the authors declare no potential conflict of interest.
Références
Biomed Res Int. 2016;2016:9079041
pubmed: 27642605
Injury. 2014 Dec;45 Suppl 6:S138-41
pubmed: 25457334
Injury. 2016 Oct;47 Suppl 4:S22-S28
pubmed: 27568843
J Biol Regul Homeost Agents. 2018 Nov-Dec;32(6 Suppl. 1):45-49
pubmed: 30644281
J Bone Joint Surg Br. 2010 Oct;92(10):1435-41
pubmed: 20884984
Expert Rev Anticancer Ther. 2014 Oct;14(10):1127-34
pubmed: 25151850
Eur Rev Med Pharmacol Sci. 2019 Apr;23(2 Suppl):252-257
pubmed: 30977892
Clin Orthop Relat Res. 2002 Feb;(395):154-63
pubmed: 11937876
J Biol Regul Homeost Agents. ;31(4 suppl 1):37-42
pubmed: 29181955
Injury. 2018 Nov;49 Suppl 3:S77-S83
pubmed: 30415673
J BUON. 2013 Apr-Jun;18(2):496-503
pubmed: 23818368
Surg Oncol. 2009 Dec;18(4):343-9
pubmed: 18835153
BMC Surg. 2018 Jan 25;18(1):5
pubmed: 29370790
Patient Saf Surg. 2013 Dec 07;7(1):37
pubmed: 24314233
J Am Acad Orthop Surg. 2016 Jul;24(7):483-94
pubmed: 27227983
J Biol Regul Homeost Agents. 2019 Mar-Apr;33(2 Suppl. 1):155-161. XIX Congresso Nazionale S.I.C.O.O.P. Societa' Italiana
pubmed: 31172733
World J Surg Oncol. 2014 Mar 01;12:48
pubmed: 24581035
J Biol Regul Homeost Agents. 2019 Mar-Apr;33(2 Suppl. 1):45-49. XIX Congresso Nazionale S.I.C.O.O.P. Societa' Italiana Ch
pubmed: 31169002
J Clin Med. 2020 Mar 11;9(3):
pubmed: 32168829
J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2):501-7
pubmed: 26122243
Br J Anaesth. 2009 Jan;102(1):12-22
pubmed: 19059919
J Surg Oncol. 2012 Feb;105(2):135-41
pubmed: 21815154